It’s about time…

for technology to

catch up.

A major challenge facing modern medicine is how to quickly and accurately establish which antibiotic will be most effective at treating an infection before the patient’s condition deteriorates over time. 

Innovation is bounding forward in healthcare. However, diagnosis of UTIs still depend on paper dipsticks, inconclusive results, subjective observation of clinical symptoms and laboratory culture and sensitivity testing that requires time to process. 

Our ground-breaking technology allows users to detect bacterial growth and predict antimicrobial sensitivity at the point of care within minutes rather than days.

Time matters for UTI sufferers.

It is estimated that over 150 million worldwide people suffer a UTI each year, and they are a growing cause of mortality. There is a significant increase in UTIs developing into the more serious urosepsis if treatment isn’t timely or effective. Sepsis is a serious condition and is responsible for over 11 million deaths worldwide - the elderly and young people are disproportionately affected. 

It’s about time to find a way to reduce UTI suffering. People often suffer in silence as they experience painful urination, burning, pressure, urgency and frequency while they wait for the most effective treatment to be identified. 

ODx wants to help all who suffer from UTIs. You too can help ease this suffering by taking part in our research.

Time is running out.

Imagine a world where medicine doesn't work. Over time the treatments we use are becoming less effective. Antibiotic resistance is a growing threat due to high use of broad spectrum, non-targeted antibiotics and is compounded by general antibiotic overuse. Broad spectrum antibiotics can't tell good and bad bugs apart, so they kill them all. Sometimes only resistant strains are left behind allowing them to become even stronger. 

UTIs are a leading source of antibiotic prescribing with many bacteria becoming immune over time to previously effective antibiotic treatments. The race is on to discover new ways to keep our medicines working.